+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

FzioMed Inc - Product Pipeline Analysis, 2020 Update

  • PDF Icon

    Company Profile

  • 26 Pages
  • June 2020
  • GlobalData
  • ID: 5118904
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.


FzioMed Inc (FzioMed) is a medical device company that develops, manufactures and commercializes surgical biomaterials. The company offers adhesion barrier gel and amniotic membrane. Its products are used in the therapeutic areas of decompression spine surgery, tendon and peripheral nerve surgery, peritoneal surgery, gynecological surgery, general surgery, tendon repair, orthopedic procedures, shoulder repair and wound repair, among others. FzioMed's absorbable adhesion barrier gel is used for peritoneal and abdominal surgery to help reduce the incidence, extent, and severity of postoperative adhesions. Its products are developed based on the combination of biocompatible medical polymers, carboxymethylcellulose and polyethylene oxide. The company sells products through a network of distributors located across Asia, Europe, North America, Middle East, South America and Africa. FzioMed is headquartered in San Luis Obispo, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company FzioMed Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

FzioMed Inc Company Overview
  • FzioMed Inc Company Snapshot
  • FzioMed Inc Pipeline Products and Ongoing Clinical Trials Overview
  • FzioMed Inc – Pipeline Analysis Overview
  • FzioMed Inc - Key Facts
  • FzioMed Inc - Major Products and Services
  • FzioMed Inc Pipeline Products by Development Stage
  • FzioMed Inc Ongoing Clinical Trials by Trial Status

FzioMed Inc Pipeline Products Overview
  • Oxiplex
  • Oxiplex Product Overview
  • Oxiplex Clinical Trial
  • Oxiplex/AP
  • Oxiplex/AP Product Overview
  • Oxiplex/IU
  • Oxiplex/IU Product Overview
  • FzioMed Inc - Key Competitors
  • FzioMed Inc - Key Employees
  • FzioMed Inc - Locations And Subsidiaries
  • Head Office

Recent Developments
  • FzioMed Inc, Recent Developments
  • Mar 28, 2019: FzioMed enrolls patient number fifty in clinical study to support the effectiveness and safety of Oxiplex for the reduction of pain and symptoms following lumbar surgery
  • Oct 03, 2018: FzioMed announces a new anti-adhesion product: Oxiplex/IU adhesion barrier gel for intrauterine surgery
  • Jan 10, 2018: FzioMed Announces 500,000 Units of Oxiplex Shipped Worldwide
  • Oct 23, 2017: FzioMed Receives FDA Approval for Small Confirmatory Study of Oxiplex in Patients Undergoing Lumbar Surgery for Disc Herniation
  • Jul 08, 2015: FzioMed Announces Sale of 400,000th Unit of Oxiplex
  • Jul 21, 2014: FzioMed announces new patent issuance in the European Union
  • May 28, 2014: FzioMed Announces Postponement of Dispute Resolution Panel for Oxiplex PMA
  • Apr 11, 2014: FzioMed Announces Date for Medical Device Dispute Resolution Panel on Oxiplex
  • Nov 04, 2013: FDA Grants FzioMed an Independent Review of its Oxiplex Gel by the Medical Devices Dispute Resolution Panel
  • May 06, 2013: FzioMed Obtains Approval For Dynavisc In Australia

  • Methodology
  • About the Publisher
  • Contact
  • Disclaimer

List of Tables
  • FzioMed Inc Pipeline Products and Ongoing Clinical Trials Overview
  • FzioMed Inc Pipeline Products by Equipment Type
  • FzioMed Inc Pipeline Products by Indication
  • FzioMed Inc Ongoing Clinical Trials by Trial Status
  • FzioMed Inc, Key Facts
  • FzioMed Inc, Major Products and Services
  • FzioMed Inc Number of Pipeline Products by Development Stage
  • FzioMed Inc Pipeline Products Summary by Development Stage
  • FzioMed Inc Ongoing Clinical Trials by Trial Status
  • FzioMed Inc Ongoing Clinical Trials Summary
  • Oxiplex - Product Status
  • Oxiplex - Product Description
  • Oxiplex - Confirmatory Clinical Study to Support the Effectiveness and Safety of Oxiplex for the Reduction of Pain and Symptoms Following Lumbar Surgery
  • Oxiplex/AP - Product Status
  • Oxiplex/AP - Product Description
  • Oxiplex/IU - Product Status
  • Oxiplex/IU - Product Description
  • FzioMed Inc, Key Employees
  • Glossary

List of Figures
  • FzioMed Inc Pipeline Products by Equipment Type
  • FzioMed Inc Pipeline Products by Development Stage
  • FzioMed Inc Ongoing Clinical Trials by Trial Status

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Innovative Medical Products Inc
  • Riverpoint Medical
  • Starch Medical Inc